Kelly Brewer, Ph.D. joined Hamilton Brook Smith Reynolds as a Patent Agent supporting our Life Sciences practice.

Kelly Brewer assists with patent preparation and prosecution in the areas of biotechnology, life sciences, biologics, immunotherapies, and bioinformatics.

Kelly’s diverse scientific experience spans the fields of cancer biology, genetics, genomics, endocrinology, bioinformatics, molecular biology, biophysics, and immunology. Kelly earned her Ph.D. in Biomedical Science with a concentration in Genetics and Developmental Biology from the University of Connecticut.

Read Kelly's full biography.

Giovanna Fessenden, Counsel and Digital IP Specialist at Hamilton Brook Smith Reynolds, co-moderated the recent event discussion on the Future of Medicine at the Berkshire Innovation Center. Panelists shared how the future of mind/body/medicine/technology innovations are enabling humans to live a healthier and longer life of intention.

As of June 6, 2023, the United States Patent and Trademark Office (USPTO) expanded the scope of the Climate Change Mitigation Pilot Program, initially implemented on June 3, 2022, to incentivize climate change innovation. The pilot program now covers a broader range of technologies designed to make progress toward achieving net-zero greenhouse gas emissions. Net-zero greenhouse gas emissions refers to the balance between the amount of greenhouse gas that is produced and the amount that is removed from the atmosphere. Qualifying technologies include the removal of greenhouse gases already present in the atmosphere, reduction and/or prevention of additional greenhouse gas emissions, and/or monitoring, tracking, and verifying greenhouse gas reductions.

Continue reading the full alert.

Christine Wise

Alice Carroll

Giovanna Fessenden, Counsel and Digital IP Specialist at Hamilton Brook Smith Reynolds, is the Co-Organizer, Executive Producer, and Curator of the TEDx Berkshires event taking place on July 22nd. Giovanna has been assisting Ethan Berg, TEDx Berkshires Director Emeritus, with TEDx Berkshires for nearly 10 years. She is also a former TEDx Berkshires speaker on the Blockchain Revolution.

Judy White, Director of Marketing at Hamilton Brook Smith Reynolds, is also on the TEDx Berkshires committee. She worked on recruiting speakers, event organization and marketing for the event.

The Event

The Berkshire Innovation Center is honored to be organizing and hosting TEDx Berkshires. We will be converting our main event space into an originally designed and outfitted TEDx studio set. We envision TEDx Berkshires to be a fun and intimate event of people coming together to hear from terrific speakers.

See the full listing of the 2023 TEDx Berkshire Speakers.

Giovanna Fessenden was recently featured in June’s Berkshire Business Journal. She talks about her excitement for this year's TEDx Berkshires event and the natural fit of hosting at the Berkshire Innovation Center. Read the full article here. (see page 19)

The Supreme Court has issued its ruling in Amgen v. Sanofi, affirming the Federal Circuit’s conclusion that Amgen failed “to enable any person skilled in the art . . . to make and use the [invention]” as recited by the relevant claims in two 2014 patents: U.S. Patent No. 8,829,165 and U.S. Patent No. 8,859,741.

Amgen and Sanofi market low-density lipoprotein (LDL) cholesterol-lowering antibody drugs. Amgen markets Repatha® (evolocumab), and Sanofi markets Praluent® (alirocumab). Amgen sued Sanofi for infringement of certain claims of the ’165 patent and the ’741 patent. In response, Sanofi asserted that the claims were invalid for lack of enablement. The District Court and The Federal Circuit agreed that the claims were not enabled, and Amgen appealed.

Continue reading the full alert.

Deirdre E. Sanders

Bin Wang, Ph.D.